Patient reporting suggests that the physical and psychological effects of autoimmune
hepatitis (AIH) can be substantial. However, health‐related quality of life (HRQOL) in
patients with AIH remains incompletely characterized, and health utility remains to be
explored. Treatment for AIH often includes the use of corticosteroids, which are agents that
can be associated with significant adverse effects. Here we explore the impact of AIH and its
treatments on patient‐reported HRQOL and health utility in a large cohort of prevalent cases …